Generic Pharmaceutical industry is facing cogent demand from the market to demonstrate what value their products can offer or if they address any unmet needs. The need for innovative products, services and new therapies are influenced and dictated by these changes. The pharmaceutical industry’s traditional R&D model has declined with a lesser number of NCEs (new chemical entities), resulting in the generic pharmaceutical industry focusing on innovations in the formulation.
Lyrus has a dedicated, certified and well equipped research facility with a pool of scientists having extensive experience in all aspects of pharmaceutical development process. Various teams can support each program with innovative and flexible solutions to make your drug product suitable for global markets, seamlessly and efficiently. Furthermore, our dedication to service also ensures that we deliver a cost effective yet quality product on time.
Our focus remains on offering challenging and value added solutions with the help of NDDS, platform technologies and innovative solutions. Lyrus, in its constant quest to offer a wide spectrum of products and dosage forms has advanced with multiple niche products, controlled release dosages, and more in ethical as well as OTC and complementary medicine segment.